TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 54 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -75.0% | 3,000 | -66.7% | 0.00% | – |
| Q3 2018 | $8,000 | 0.0% | 9,000 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | +14.3% | 9,000 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | 0.0% | 9,000 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $7,000 | -12.5% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | -11.1% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $9,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |